Covestor LTD Stoke Therapeutics, Inc. Transaction History

Covestor LTD

$150 Million
Q1 2025

A detailed history of Covestor LTD transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Covestor LTD holds 2,417 shares of STOK stock, worth $30,212. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,417

Holding current value

$30,212

% of portfolio

0.01%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$6.65 - $12.74 $16,073 - $30,792	2,417 New	2,417 $16,000
Q1 2022 May 13, 2022	SELL	$17.19 - $26.1 $0 - $0	0 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$18.11 - $30.72 $0 - $0	0 New	0 $0

Others Institutions Holding STOK

# of Institutions

136

Shares Held

56.4M

Call Options Held

5.6K

Put Options Held

142K

Black Rock Inc. New York, NY

5.41M
Shares

$67.6 Million
0.0% of portfolio
Lynx1 Capital Management LP San Juan, PR

5.29M
Shares

$66.1 Million
13.01% of portfolio
Rtw Investments, LP New York, NY

5.12M
Shares

$64 Million
0.56% of portfolio
Baker Bros. Advisors LP New York, NY

4.63M
Shares

$57.9 Million
0.37% of portfolio
Redmile Group, LLC San Francisco, CA

4.49M
Shares

$56.1 Million
3.13% of portfolio

View Full List

About Stoke Therapeutics, Inc.

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $493M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

More about STOK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account